Fundz

N-Power Medicine closes $32 million Series B financing to expand its oncology network and accelerate ProECA adoption.

PRIVATESep 01, 2026

Amount Raised

$32 Million

Round Type

Series B

Redwood CityBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Investors

Merck Global HealthLabcorp Venture Fund

Description

N-Power Medicine has announced the close of a $32 million Series B financing round. This funding will help the company expand its community oncology network and deepen partnerships with pharmaceutical companies. Additional investment will be directed towards product development. New investor Labcorp Venture Fund participated in this round alongside Merck Global Health.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as N-Power Medicine that raised within 45 days of this round, from Fundz verified event records.

  • Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
  • Os Therapies raised $7.2M on October 15, 2026.
  • Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
  • Tivic raised $8.4M (Series B) on October 8, 2026.
  • Rouge Therapeutics raised $58M (Series A) on October 6, 2026.
  • Omnio raised $3.3M (Seed) on October 2, 2026.

Who to call at N-Power Medicine, and when

A new round usually means N-Power Medicine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day N-Power Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at N-Power Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at N-Power Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

N-Power Medicine

Location

Redwood City, California, United States

About

N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to support clinical trials and drug development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment N-Power Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMark, CEO & Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for N-Power Medicine's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

N-Power Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.